COVID-19 vaccination figures more up-to-date due to optimised monitoring RIVM has been publishing national and regional figures on COVID-19 vaccination in the Netherlands every week since 19 January 2021.
Cost-effective risk assessment of nanomaterials may be feasible Companies, authorities and scientists can save time, money and test animals in the risk assessment of nanomaterials by using available data.